RCAMU
HAE icon

Rothschild & Co Asset Management US’s Haemonetics HAE Stock Holding History

Rothschild & Co Asset Management US’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-38,493
Closed -$3.45M – 375
2018
Q2 		$3.45M Sell
38,493
-37,112
-49% -$3.13M 0.04% 314
2018
Q1 		$5.53M Sell
75,605
-8,129
-10% -$558K 0.06% 285
2017
Q4 		$4.86M Sell
83,734
-5,444
-6% -$287K 0.05% 284
2017
Q3 		$4M Buy
89,178
+1,320
+2% +$54.8K 0.04% 283
2017
Q2 		$3.47M Buy
87,858
+269
+0.3% +$11K 0.04% 295
2017
Q1 		$3.55M Sell
87,589
-3,656
-4% -$143K 0.04% 292
2016
Q4 		$3.67M Buy
91,245
+5,066
+6% +$191K 0.05% 304
2016
Q3 		$3.12M Buy
86,179
+73
+0.1% +$2.51K 0.05% 291
2016
Q2 		$2.5M Sell
86,106
-5,493
-6% -$166K 0.05% 308
2016
Q1 		$3.2M Sell
91,599
-2,716
-3% -$87.7K 0.06% 286
2015
Q4 		$3.04M Sell
94,315
-341,399
-78% -$11.1M 0.06% 298
2015
Q3 		$14.1M Buy
435,714
+11,665
+3% +$439K 0.28% 128
2015
Q2 		$17.5M Buy
424,049
+17,183
+4% +$724K 0.32% 101
2015
Q1 		$18.3M Sell
406,866
-14,705
-3% -$615K 0.35% 97
2014
Q4 		$15.8M Buy
+421,571
New +$15.4M 0.31% 102

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Rothschild & Co Asset Management US's HAE Position: Q3 2018 in Review

Rothschild & Co Asset Management US sold out of Haemonetics (HAE) in Q3 2018, closing a stake of 38,493 shares — an estimated $3.45M sold.

Rothschild & Co Asset Management US first reported a position in HAE in Q4 2014 and held it in 15 quarters. The position peaked at $18.3M in Q1 2015. 292 funds tracked by Wall St. Rank hold HAE as of Q3 2018.

  • Rothschild & Co Asset Management US reported no remaining Haemonetics position as of Q3 2018 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 38,493 Haemonetics shares in Q3 2018, an estimated $3.45M.
  • Rothschild & Co Asset Management US first reported a position in Haemonetics in Q4 2014 and held it in 15 quarters.
  • Rothschild & Co Asset Management US's Haemonetics position peaked at $18.3M in Q1 2015.
  • 292 funds tracked by Wall St. Rank held Haemonetics as of Q3 2018.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2018, filed 13 Nov 2018.